N-Boc-4-Piperidineethanol CAS 89151-44-0 Puritas >98.0% (GC)

Description:

Chemical Name: N-Boc-4-Piperidineethanol

CAS: 89151-44-0

Puritas: >98.0% (GC)

Aspectus: Yellow ut pallide flavis Liquid

High Quality, Commercial Production

Mobile/Wechat/Whatsapp: +86-15026746401

E-Mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Shanghai Ruifu Chemical Co., Ltd. est primarius fabrica et elit N-Boc-4-Piperidineethanol (CAS: 89151-44-0) magna qualitate.CoA praebere possumus, totius orbis partus, parvas et parvas quantitates in promptu habentes.Si interesse in hoc facto, singula informationes mittas mitte nobis numerum CAS, nomen productum, quantitatem nobis.Please contact: alvin@ruifuchem.com

Chemical Properties:

Nomen chemicum	N-Boc-4-Piperidineethanol
Synonyma	1-Boc-4-(2-Hydroxyethyl) piperidine;1-Boc-4-(2-Hydroxy-Ethyl)-Piperidine;Boc-2-(4-piperidyl)ethanol;tert-Butyl 4-(2-Hydroxyethyl) piperidine-1-Carboxylata;4-(2-Hydroxyethyl) piperidine-1-Carboxylic Acidum tert-Butyl Ester;N-tert-Butoxycarbonyl-4-Piperidineethanol;N-(tert-Butoxycarbonyl) -4-Piperidineethanol
CAS Number	89151-44-0
CATTUS Number	RF2716
Stock Status	In Stock, Productio Ascendite ad Tons
Formulae hypotheticae	C12H23NO3
M. Pondus	229.32
Ferveret	120.0~150.0℃/0.5 mmHg (lit.)
Density	1.043 g/mL ad 25℃(lit.)
Index refractivus n20/D	1.472~ 1.474 (lit.)
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Flavo pallide flavus Liquid
Puritas / Analysis Methodus	>98.0% (GC)
Aqua (auctore Karl Fischer)	<0.50%
Totalis immunditias	<2.00%
Infrared Imaginis	Conformat ut Structure
Proton NMR Spectrum	Conformat ut Structure
Test Standard	Enterprise Standard
Consuetudinem	Pharmaceutical intermedia

Sarcina & Repono:

sarcina: Fluorinated Utrem, 25kg/ Ferocactus, vel secundum exigentiam elit

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

Satis capacitas: sufficientes facilities et technici

Professional Service: One stop acquireing service

Altera Package: Custom sarcina ac titulus praesto

Ieiunium Delivery: Si intra stirpem, tres dies partus praestatur

Supple firmum: Esse rationabile stirpe

Technical Support: Technology solution praesto

Custom Synthesis Service: Range from P. to kilos

High Quality: Constitutus ratio completa qualitas certitudinis

FAQ:

Quam mercari?Please contact: sales@ruifuchem.com or alvin@ruifuchem.com

15 Years Experience?Plus quam XV annos experientiae habemus in fabricando et exportando amplis intermediis pharmaceuticis vel alchimicis pharmaceuticis amplis.

Mercatus principalis?Vendere mercatum domesticum, Americam septentrionalem, Europam, Indiam, Russiam, Coream, Iaponicam, Australiam etc.

Commodi?Superior qualitas, parabilis pretium, officia professionalia et subsidia technica, ieiunium partus.

Qualitasfides?Qualitas strictioris temperantiae ratio.Pro instrumento analysi professionali includuntur NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Claritas, Solubilitas, Microbialis limes test, etc.

Exempla?Pleraque producta praebent exempla gratuita pro qualitate aestimationis, sumptus naviculas a clientibus solvendos.

Factory Audit?Factory audit gratissimum.Quaeso ante constitutum.

MOQ?Nec MOQ.Parvus ordo placet.

Tempus adferendi? Si intus prosapia, tres dies partus praestatur.

Transportatio?Per Express (FedEx, DHL), ab Air, per Mare.

Documenta?Post servitium venditionis: COA, MOA, ROS, MSDS, etc. praeberi possunt.

Consuetudo Synthesis?Consuetudo synthesis officia praebere potest ad optimas investigationes tuas necessitates aptandas.

Pensio conditio?Proforma cautionis primum post confirmationem ordinis mittetur, informationes nostrae ripae inclusas.Payment by T/T (Telex Transfer), PayPal, Western Union, etc.

Applicatio:

N-Boc-4-Piperidineethanol (CAS: 89151-44-0) adhibetur ut medium organicum vel pharmaceuticum.N-Boc-4-Piperidineethanol adhibetur ad praeparandum anilinoquinazolinum VEGF receptor tyrosinus kinasus inhibitores cum actionibus antitumoris.Solet etiam synthesizare 1,3,4-trisubstitutam pyrrolidinem CCR5 receptoris antagonistae cum actionibus antiviralibus.